155 related articles for article (PubMed ID: 19958394)
21. [The role of cardiopulmonary exercise testing in the assessment of pulmonary hypertension].
Dumitrescu D; Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S176-9. PubMed ID: 18814090
[TBL] [Abstract][Full Text] [Related]
22. Clinical perspective: biomarkers in pulmonary arterial hypertension.
Heresi GA
Int J Clin Pract Suppl; 2011 Jan; (169):5-7. PubMed ID: 21176009
[TBL] [Abstract][Full Text] [Related]
23. [Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension].
Avdeev SN
Ter Arkh; 2014; 86(3):88-93. PubMed ID: 24779077
[TBL] [Abstract][Full Text] [Related]
24. Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
Waxman AB; Farber HW
Circulation; 2015 Dec; 132(22):2152-61. PubMed ID: 26621638
[No Abstract] [Full Text] [Related]
25. Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertension.
Haworth SG; Beghetti M
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S35-41. PubMed ID: 20375663
[TBL] [Abstract][Full Text] [Related]
26. New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension.
Preston IR; Suissa S; Humbert M
Eur Respir Rev; 2013 Dec; 22(130):495-502. PubMed ID: 24293465
[TBL] [Abstract][Full Text] [Related]
27. [Use of the six-minute walk test in cardiology].
Kervio G; Ville NS; Leclercq C; Daubert JC; Carré F
Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1219-24. PubMed ID: 16435601
[TBL] [Abstract][Full Text] [Related]
28. Management of dyspnea in advanced pulmonary arterial hypertension.
Sajkov D; Petrovsky N; Palange P
Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
[TBL] [Abstract][Full Text] [Related]
29. [Six minutes walk for the assessment of patients with chronic obstructive pulmonary disease].
Lisboa B C; Barría P P; Yáñez V J; Aguirre Z M; Díaz P O
Rev Med Chil; 2008 Aug; 136(8):1056-64. PubMed ID: 18949192
[TBL] [Abstract][Full Text] [Related]
30. [Assessment of cardiopulmonary function at rest and during exercise in patients with pulmonary hypertension].
Ewert R; Opitz CF; Wensel R; Halank M; Winkler J; Lodziewski S; Felix SB
Herz; 2005 Jun; 30(4):318-25. PubMed ID: 15965809
[TBL] [Abstract][Full Text] [Related]
31. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
32. End points and clinical trial design in pulmonary arterial hypertension.
McLaughlin VV; Badesch DB; Delcroix M; Fleming TR; Gaine SP; Galiè N; Gibbs JSR; Kim NH; Oudiz RJ; Peacock A; Provencher S; Sitbon O; Tapson VF; Seeger W
J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S97-S107. PubMed ID: 19555863
[TBL] [Abstract][Full Text] [Related]
33. Assessing effectiveness of pulmonary arterial hypertension therapies in daily practice.
Sitbon O; Hoeper MM; Simonneau G
Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S21-6. PubMed ID: 20375661
[TBL] [Abstract][Full Text] [Related]
34. The 6-minute walk test in scleroderma--how measuring everything measures nothing.
Impens AJ; Wangkaew S; Seibold JR
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v68-9. PubMed ID: 18784152
[TBL] [Abstract][Full Text] [Related]
35. [Investigation of pulmonary hypertension].
Natali D; Simonneau G; Humbert M; Montani D
Rev Pneumol Clin; 2008 Jun; 64(3):151-61. PubMed ID: 18656791
[TBL] [Abstract][Full Text] [Related]
36. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
[TBL] [Abstract][Full Text] [Related]
37. [Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment].
Can MM; Kaymaz C
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():36-42. PubMed ID: 20819765
[TBL] [Abstract][Full Text] [Related]
38. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
[TBL] [Abstract][Full Text] [Related]
39. The six-minute walk test: a useful metric for the cardiopulmonary patient.
Rasekaba T; Lee AL; Naughton MT; Williams TJ; Holland AE
Intern Med J; 2009 Aug; 39(8):495-501. PubMed ID: 19732197
[TBL] [Abstract][Full Text] [Related]
40. Field tests of exercise in COPD: the six-minute walk test and the shuttle walk test.
Brown CD; Wise RA
COPD; 2007 Sep; 4(3):217-23. PubMed ID: 17729065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
